Stocks of Malaysia Upper glove, the world’s largest manufacturer of medical gloves, are down more than 50% this year as the global roll out of Covid-19 vaccinations dampened demand for gloves.

“As in any business, there are always ups and downs. And you can’t expect super wins to last for a long, long time. So we’re glad we had a good run last year, “Lee Kim Meow, Top Glove CEO told CNBC:”Road signs Asia” on Monday.

The company on Friday announced a 48% year-over-year decline in net income to 608 million Malaysian ringgits ($ 145.11 million) for the June-August period. Sales were around 2.1 billion ringgits, 32% less than a year ago.

The results were “weaker due to the normalizing demand for the global introduction of vaccines, resulting in lower sales volumes and [average selling prices]that weren’t offset by a corresponding cut in commodity prices, “Top Glove said in his annual accounts.

As in any business, there are always ups and downs. And you can’t expect super wins to last for a long, long time.

Lee Kim Meow

Managing director, top glove

In addition, the company’s sales were increased by a US import ban on charges of forced labor. The ban has been lifted earlier this month.

Top Glove shares in Malaysia fell more than 5% on Monday, increasing their year-to-date losses to over 52%.

Other Malaysian glove inventories also declined, with Hartalega, Super max and Kossan recorded losses of between 3% and 5% on Monday.

In comparison, is the benchmark stock index FTSE Bursa Malaysia KLCI index down less than 1% on the same day.

Last year, Top Glove’s shares rose 290% as they posted record sales and earnings, thanks increasing demand for gloves during the pandemic.

Listing in Hong Kong

Upper glove delayed a plan to pursue “dual primary listing” to raise $ 1 billion on the Hong Kong Stock Exchange after the company was hit with the US import ban.

Lee told CNBC the company wanted to continue listing. Top Glove already has a main listing in Malaysia and a Second listing in Singapore.

“We felt that, for the sake of long-term business, in order to move forward and see the benefits of being listed in Hong Kong, we had to see this as something we had to go through,” said the executive director.

“A listing in Hong Kong will put us in a good position to be where we want to be to achieve our dream of being a Fortune Global 500 company in 2030,” he added.